---
title: "FreeStyle Libre: FreeStyle Libre 3 and 3 Plus Glucose monitoring sensors — FDA announcement Jan 15, 2026 | Is It on Recall"
description: "Internal testing determined that some sensors may provide incorrect low glucose readings."
url: https://isitonrecall.com/recall/fdapress-23e244c6ea16b211-freestyle-libre-freestyle-libre-3-and-3-plus-glucose-monitoring-sensors/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# FreeStyle Libre: FreeStyle Libre 3 and 3 Plus Glucose monitoring sensors — FDA announcement Jan 15, 2026

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jan 15, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: FreeStyle Libre 3 and 3 Plus Glucose monitoring sensors
- **Reason**: Internal testing determined that some sensors may provide incorrect low glucose readings.
- **Classification**: Not supplied
- **Recalling firm**: Abbott
- **Quantity**: Not supplied
- **Agency-reported status**: Company recall announcement
- **Source record identifier**: 23e244c6ea16b211

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abbott-initiates-medical-device-correction-certain-freestyle-librer-3-and-freestyle-libre-3-plus)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Not supplied |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Fda listing date**: Jan 15, 2026
- **Company announcement date**: Nov 24, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers should visit www.FreeStyleCheck.com to confirm whether their sensor is potentially affected by this medical device correction. Abbott will replace any potentially affected sensors at no charge. Detailed instructions on how to check sensors and request a replacement are available on www.FreeStyleCheck.com. Consumers should use a blood glucose meter or the built-in meter in the FreeStyle Libre 3 reader to make treatment decisions when sensor readings don’t match symptoms or expectations.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abbott-initiates-medical-device-correction-certain-freestyle-librer-3-and-freestyle-libre-3-plus)

## Related records

[Medical devices records](https://isitonrecall.com/category/medical-devices/) [Abbott records](https://isitonrecall.com/brand/abbott/)